These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 21414525)

  • 1. [Cannabinoid applications in glaucoma].
    Pinar-Sueiro S; Rodríguez-Puertas R; Vecino E
    Arch Soc Esp Oftalmol; 2011 Jan; 86(1):16-23. PubMed ID: 21414525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of endogenous, phyto and synthetic cannabinoids on thrombogenesis and platelet activity.
    Grambow E; Strüder D; Klar E; Hinz B; Vollmar B
    Biofactors; 2016 Nov; 42(6):581-590. PubMed ID: 27151562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indirect sympatholytic actions at β-adrenoceptors account for the ocular hypotensive actions of cannabinoid receptor agonists.
    Hudson BD; Beazley M; Szczesniak AM; Straiker A; Kelly ME
    J Pharmacol Exp Ther; 2011 Dec; 339(3):757-67. PubMed ID: 21885619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson's disease: importance of antioxidant and cannabinoid receptor-independent properties.
    García-Arencibia M; González S; de Lago E; Ramos JA; Mechoulam R; Fernández-Ruiz J
    Brain Res; 2007 Feb; 1134(1):162-70. PubMed ID: 17196181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabinoids inhibit sodium-dependent, high-affinity excitatory amino acid transport in cultured rat cortical astrocytes.
    Shivachar AC
    Biochem Pharmacol; 2007 Jun; 73(12):2004-11. PubMed ID: 17445778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cannabinoid receptor agonists, anandamide and WIN 55,212-2, do not directly affect mu opioid receptors expressed in Xenopus oocytes.
    Kracke GR; Stoneking SP; Ball JM; Tilghman BM; Washington CC; Hotaling KA; Johnson JO; Tobias JD
    Naunyn Schmiedebergs Arch Pharmacol; 2007 Dec; 376(4):285-93. PubMed ID: 17960365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of CB1 and CB2 receptors in the modulation of cholinergic neurotransmission in mouse gastric preparations.
    Mulè F; Amato A; Baldassano S; Serio R
    Pharmacol Res; 2007 Sep; 56(3):185-92. PubMed ID: 17656103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of WIN 55212-2, a cannabinoid receptor agonist, on aqueous humor dynamics in monkeys.
    Chien FY; Wang RF; Mittag TW; Podos SM
    Arch Ophthalmol; 2003 Jan; 121(1):87-90. PubMed ID: 12523891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysregulation of the endogenous cannabinoid system in adult rats prenatally treated with the cannabinoid agonist WIN 55,212-2.
    Castelli MP; Paola Piras A; D'Agostino A; Pibiri F; Perra S; Gessa GL; Maccarrone M; Pistis M
    Eur J Pharmacol; 2007 Nov; 573(1-3):11-9. PubMed ID: 17644084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabinoid receptor-mediated regulation of neuronal activity and signaling in glomeruli of the main olfactory bulb.
    Wang ZJ; Sun L; Heinbockel T
    J Neurosci; 2012 Jun; 32(25):8475-9. PubMed ID: 22723687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabinoid-induced changes in respiration of brain mitochondria.
    Fišar Z; Singh N; Hroudová J
    Toxicol Lett; 2014 Nov; 231(1):62-71. PubMed ID: 25195527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective effects of topical CB1 agonist WIN 55212-2 on retinal ganglion cells after acute rise in intraocular pressure induced ischemia in rat.
    Pinar-Sueiro S; Zorrilla Hurtado JÁ; Veiga-Crespo P; Sharma SC; Vecino E
    Exp Eye Res; 2013 May; 110():55-8. PubMed ID: 23454099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The arguments for and against cannabinoids application in glaucomatous retinopathy.
    Panahi Y; Manayi A; Nikan M; Vazirian M
    Biomed Pharmacother; 2017 Feb; 86():620-627. PubMed ID: 28027538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for a modulatory role of cannabinoids on the excitatory NANC neurotransmission in mouse colon.
    Mulè F; Amato A; Baldassano S; Serio R
    Pharmacol Res; 2007 Aug; 56(2):132-9. PubMed ID: 17574859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonpsychotropic cannabinoids, abnormal cannabidiol and canabigerol-dimethyl heptyl, act at novel cannabinoid receptors to reduce intraocular pressure.
    Szczesniak AM; Maor Y; Robertson H; Hung O; Kelly ME
    J Ocul Pharmacol Ther; 2011 Oct; 27(5):427-35. PubMed ID: 21770780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Endocannabinoid System as a Therapeutic Target in Glaucoma.
    Cairns EA; Baldridge WH; Kelly ME
    Neural Plast; 2016; 2016():9364091. PubMed ID: 26881140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cannabinoid agonist WIN 55,212-2 inhibits TNF-alpha-induced neutrophil transmigration across ECV304 cells.
    Nilsson O; Fowler CJ; Jacobsson SO
    Eur J Pharmacol; 2006 Oct; 547(1-3):165-73. PubMed ID: 16928371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabinoids in the treatment of glaucoma.
    Järvinen T; Pate DW; Laine K
    Pharmacol Ther; 2002 Aug; 95(2):203-20. PubMed ID: 12182967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The synthetic cannabinoid WIN55212-2 decreases the intraocular pressure in human glaucoma resistant to conventional therapies.
    Porcella A; Maxia C; Gessa GL; Pani L
    Eur J Neurosci; 2001 Jan; 13(2):409-12. PubMed ID: 11168547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroscience. Stout guards of the central nervous system.
    Mechoulam R; Lichtman AH
    Science; 2003 Oct; 302(5642):65-7. PubMed ID: 14526067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.